Author

Pieter Hindryckx 1

1 Department of Gastroenterology,Ghent University Hospital,Ghent,Belgium

Case presentation

Pieter Hindryckx

Case presentation

Pieter Hindryckx

HETEROGENEITY IN THE ENDOSCOPIC MANAGEMENT OF CROHN’S DISEASE ASSOCIATED STRICTURES: RESULTS FROM AN INTERNATIONAL INFLAMMATORY BOWEL DISEASE SPECIALIST SURVEY

Dominik Bettenworth, Rocio Lopez, Pieter Hindryckx, Barrett G. Levesque, Florian Rieder

Multicentre, retrospective, cohort study of 55 patients with Buried Bumper Syndrome treated endoscopically with a novel dedicated device

Deborah Costa, Edward J Despott, Jeremy M Woodward, Pavel Kohout, Timo Rath, Louise Scovell, Ian Gee, Pieter Hindryckx, Ewan H Forrest, Dawn Jordan, Coral Hollywood, Stephen Hearing, Imtiyaz Mohammed, Rachel Cooney, Hemant Sharma, Zeino Zieno, Ian Gooding, Nikolaos Lazaridis, Claudia Coppo, Nikolaos Koukias, Alberto Mur

Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease

Marie Truyens, Marleen Goossens, Elien Glorieus, Jeroen Geldof, Pieter Hindryckx, Triana Lobaton Ortega

EARLY FIBROSTENOSIS IN CROHN’S DISEASE IS ASSOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSIS

Tom Holvoet, Peter Bossuyt, Isabelle Cleynen, Isabelle De Kock, Pieter Hindryckx, Severine Vermeire, Debby Laukens, Martine De Vos

Efficacy of Ustekinumab intensification and re-induction in Crohn's disease patients with insufficient or loss of response

Marie Truyens, Marleen Goossens, Elien Glorieus, Jeroen Geldof, Pieter Hindryckx, Triana Lobaton Ortega

OPEN LABEL OBSERVATIONAL STUDY EVALUATING THE EFFECT OF INDUCTION THERAPY WITH VEDOLIZUMAB IN PATIENTS WITH MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE INTOLERANT/RESISTANT TO AT LEAST TWO BIOLOGICALS

Martine De Vos, Barbara Dhooghe, Severine Vermeire, Edouard Louis, Mana Fazia, An Elewaut, Peter Bossuyt, Filip Baert, Catherine Reenaers, Marc Van Gossum, Elisabeth Macken, Marc Ferrante, Pieter Hindryckx, Sophie De Wit, Tom Holvoet, Denis Franchimont

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De Galan, Sophie Van Welden, Simon Bos, Simon Tavernier, Triana Lobaton Ortega, Gerard Gonzales, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, Debby Laukens, Pieter Hindryckx

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

Fernando Jose Magro Dias, Paolo Gionchetti, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro de Acosta, Johan Burisch, Krisztina Barbara Gecse, Ailsa L Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Sylwia Zagorowicz, Tim Raine, Marcus Harbord, Florian Rieder

Item 1 - 10 / 15
1
2